Adverse reactions in children. Special considerations in prevention and management

P M Leary1

  • 1Department of Paediatrics and Child Health, University of Cape Town, South Africa.

Drug Safety
|May 1, 1991
PubMed

Insights

Pediatric drug adverse reactions are uncommon (2-5%) and usually mild. Early recognition and stopping the medication are key to managing side effects in children.

Area of Science:

  • Pediatric Pharmacology
  • Adverse Drug Reactions
  • Child Health

Background:

  • Adverse drug reactions (ADRs) in children are infrequent, affecting 2-5% of those prescribed medication.
  • Most pediatric ADRs are mild and temporary, but some can be serious, like aplastic anemia with chloramphenicol.

Purpose of the Study:

  • To review common adverse drug reactions in children.
  • To emphasize the importance of judicious drug prescribing and prompt management of side effects.

Main Methods:

  • Literature review of pediatric drug adverse reactions.
  • Discussion of specific drug classes and their associated side effects.
  • Overview of management strategies for ADRs in children.

Main Results:

  • Antimicrobials and antipyretic/analgesics are most frequently prescribed, carrying potential risks.
  • Specific drug interactions (e.g., erythromycin with carbamazepine/theophylline) and side effects (e.g., anticonvulsants on cognition, phenothiazines causing dystonia) are highlighted.
  • Effective management relies on early detection, drug withdrawal, and symptomatic treatment.

Conclusions:

  • Practitioners must be aware of drug effects and prescribe only necessary medications.
  • Limiting therapy duration and educating parents about potential adverse reactions are crucial.
  • Reporting unknown adverse reactions to monitoring authorities is an important responsibility.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...